Value Factor ETFs EU 2026: ZPRV, IWFV Deep-Dive

TL;DR

The value factor (HML — "High Minus Low" book-to-market) is one of the two original additions to the Capital Asset Pricing Model in the Fama-French three-factor model (1993). The thesis: stocks with high book-to-price ratios (cheap stocks) outperform stocks with low book-to-price ratios (growth stocks) over long horizons. Kenneth French data shows a US value premium of roughly 4% per year from 1927 through the early 2000s, falling to a premium near zero from 2010-2020 — the "value lost decade" — before a partial recovery in 2022-2024.

Top UCITS picks for value-tilted EU investors in 2026:

• SPDR MSCI USA Small Cap Value Weighted UCITS ETF (ZPRV) — TER 0.30%, AUM around 1.1 billion EUR, accumulating
• SPDR MSCI Europe Small Cap Value Weighted UCITS ETF (ZPRX) — TER 0.30%, AUM around 600 million EUR, accumulating
• iShares Edge MSCI World Value Factor UCITS ETF (IWFV / IWVL) — TER 0.30%, AUM around 4.5 billion EUR, accumulating
• Xtrackers MSCI World Value Factor UCITS ETF (XDEV) — TER 0.25%, AUM around 1.2 billion EUR, accumulating
• iShares Edge MSCI Europe Value Factor UCITS ETF (IEVL) — TER 0.25%, AUM around 800 million EUR, accumulating

Historical 5-year returns through 2025: MSCI World Value delivered around +68% cumulative vs +83% for MSCI World — still a lag but narrowing. Value's max drawdown during COVID was -32%, similar to MSCI World, but recovery was slower. 2022 was a banner year for value as growth de-rated and value held up: MSCI World Value -8% vs MSCI World -12%.

Factor investing requires long holding periods and tolerance for relative underperformance. Educational content, not advice.

What is the value factor

The value factor describes the long-run tendency of cheap stocks (measured by book-to-price, earnings yield, dividend yield, or cash-flow yield) to outperform expensive stocks. Fama and French quantified it in the 1993 three-factor model as HML — the return spread between a portfolio of high book-to-market stocks and low book-to-market stocks.

Like the small-cap factor, value has two main explanations.

Risk-based explanation: Value stocks are distressed companies in unfashionable sectors. They face higher business risk — declining industries, weak competitive moats, balance-sheet stress. Investors demand a return premium for holding them. In this framing, the value premium is risk compensation, not a free lunch.

Behavioural explanation: Investors over-extrapolate growth stories. Glamour stocks attract attention and bid up to unsustainable multiples; cheap stocks are neglected and trade below intrinsic value. Behavioural biases (representativeness, narrative dominance) sustain mispricing until reality catches up.

Both explanations are partially true. The behavioural view dominated value's golden era of the 1980s-2000s. The risk view has been more consistent with the painful 2010-2020 stretch.

How value is measured

MSCI Enhanced Value methodology (used by IWFV, XDEV) screens for three valuation metrics:

• Price-to-book — lower is better
• Price-to-forward-earnings — lower is better
• Enterprise value to operating cash flow — lower is better

The MSCI World Enhanced Value index targets approximately 30% of MSCI World market cap, ranks stocks within sectors to avoid concentration in deeply cyclical sectors (avoiding the "value trap" of being entirely energy + financials), and rebalances semi-annually.

FTSE Russell's RAFI methodology takes a different approach — weighting by fundamental measures (sales, cash flow, dividends, book value) rather than market cap. Both achieve a value tilt; the RAFI approach has slightly less factor purity but broader sector exposure.

The Fama-French academic definition uses book-to-market alone. Modern factor ETFs use composite metrics because pure book-to-market suffers from accounting distortions (intangible-asset-heavy companies like software firms have low book values that misrepresent true equity).

Critical methodology note: the rise of intangibles (R&D, software, brands) means traditional book-to-market mismeasures value for tech-heavy economies. AQR and Research Affiliates have published extensively on this — adjusting book value for capitalised intangibles partially closes the value vs growth gap of the 2010s.

Top UCITS value ETFs comparison

IWFV / IWVL is the workhorse choice for global value exposure — largest AUM, broad geographic coverage, transparent MSCI Enhanced Value methodology. ZPRV and ZPRX are smart picks for combining small-cap and value factor exposure into a single fund.

For a US-only value tilt, no large UCITS option exists with an S&P value methodology comparable to US-domiciled funds like VOOV (which is not UCITS-available). ZPRV captures US small value adequately.

Performance history

MSCI World Enhanced Value vs MSCI World, annualised total returns through 2025 (EUR-unhedged):

The pattern is stark. The very long historical record (1927-2025) shows a strong value premium of roughly 4% per year in the US. The recent 20-year record shows the premium has collapsed and even reversed for periods. Whether you treat this as evidence the factor is dead or as a once-in-a-generation mean-reversion opportunity is the central question for value investors in 2026.

Max drawdown for MSCI World Value during the 2020 COVID crash was around -34%, similar to MSCI World. During the 2008 GFC value drew down further than the broad market because financial stocks were heavily weighted in value indices. Correlation to MSCI World is around 0.88 over 10 years.

When value underperforms

The 2010-2020 value drought is one of the worst in factor history.

Lost decade specifics: MSCI World Value underperformed MSCI World by approximately 3-4 percentage points per year from 2010 to 2020. Investors holding pure value tilts saw terminal wealth roughly 35% lower than buy-and-hold MSCI World over the period.

Why: rise of intangible-heavy growth companies (FAANG, Magnificent 7), zero interest rate environment that benefitted long-duration cash flows (i.e. growth), and a structural shift in the economy toward software and services that traditional book-value-based value metrics did not capture.

Partial reversal 2021-2024: value bounced back as rates rose. 2022 specifically saw value outperform growth by 10+ percentage points as ZIRP-era valuations collapsed. But the bounce has been uneven — 2023-2024 saw growth dominate again on AI enthusiasm.

Implication: value investing requires possibly 15-20 year holding periods to ride out droughts. Investors who panic-sold during the 2018-2020 trough locked in losses just before the partial reversal. Behavioural commitment is the hardest part.

Combining factors

Pure value is volatile. Common combinations smooth the ride:

• Value + Quality (Buffett-style): combining cheap stocks with profitable high-quality businesses removes the worst value traps. AQR has long argued quality-screened value is the best version of the factor. UCITS implementation: hold IWFV + IQLT in 50/50 ratio, or use a multi-factor fund.
• Value + Small (DFA-style): small-value combinations have historically delivered the strongest premiums. ZPRV (US small value) and ZPRX (Europe small value) are direct implementations.
• Multi-factor: iShares Edge MSCI World Multifactor (IFSW) blends value, quality, momentum, size. TER 0.50%, AUM around 1 billion EUR. Performance has been respectable through the value drought because the other factors compensated.
• Equally-weighted indices: XDEW (S&P 500 Equal Weight) is a soft value tilt because mega-cap growth stocks are down-weighted relative to market cap. TER 0.20%, AUM 8 billion EUR.

The equal-weight approach has been popular as a "lazy value" alternative — no methodology debate, just don't over-weight the top 10 stocks. Performance has roughly matched dedicated value factor funds over 2020-2025 with lower tracking error.

Tax treatment across EU jurisdictions

Germany: Vorabpauschale applies to accumulating value UCITS ETFs (IWFV, ZPRV, XDEV). Teilfreistellung of 30% applies for equity funds. Capital gains taxed at 25% + Soli + church tax. Distributing value funds (some IEVL share classes) generate dividend income subject to the same rates.

France: PEA requires 75% EU equity exposure. MSCI World Value funds (IWFV, XDEV) do not qualify. IEVL (MSCI Europe Value) holds primarily EU-listed companies but typically does not qualify because the fund itself is IE-domiciled rather than EU-eligible-share-class. Verify the specific share class. Outside PEA, gains are subject to PFU at 30%.

Italy: 26% capital gains tax with 0.20% per year stamp duty. Capital losses only offset capital gains (not dividends). Same treatment as any UCITS ETF.

Spain: 19-28% progressive capital gains. Lack of ETF traspaso is a structural disadvantage for active rebalancing across value/growth factors. Consider lower turnover or use Spanish mutual fund equivalents where available.

Poland: Belka tax of 19%. IKE / IKZE wrappers eliminate or defer the tax. https://bossa.pl and https://www.mbank.pl list IWFV, XDEV, ZPRV, ZPRX, IEVL on Xetra and other EU exchanges. Long-horizon value bets are particularly well suited to IKE because the tax-free withdrawal at age 60 offsets the long drought risk.

Broker availability and savings plans

• Trade Republic: IWFV / XDEV / ZPRV / ZPRX / IEVL all available, savings plan eligible at zero cost from 1 EUR per execution
• Scalable Capital: same fund list, all savings plan eligible
• DEGIRO core selection: IWFV typically included; ZPRV / ZPRX availability varies
• Interactive Brokers: full UCITS value range available, low fixed commissions
• mBank Brokers / BOSSA: IWFV, XDEV, ZPRV, ZPRX available, IKE / IKZE eligible

Savings plans into value ETFs are common among investors implementing factor tilts via dollar-cost averaging.

When value makes sense in a portfolio

Many investors include 5-15% value exposure alongside a market-cap core. The case for value in 2026 rests on:

• Mean-reversion expectation: the value drought of 2010-2020 was historically extreme. Either the factor is structurally dead, or a meaningful mean reversion is overdue. If the latter, current expected value premium is above the long-term average.
• Valuation spread: as of early 2026, the spread between value and growth valuations is wider than at most points in history, second only to the late 1990s dot-com peak.
• Behavioural diversification: holding a value satellite reduces concentration in mega-cap growth stocks, which dominate MSCI World by approximately 25% weight in the top 10 holdings.

Typical allocations for value-tilted EU portfolios:

• 70-80% global core (VWCE or IWDA)
• 10-15% value (IWFV or XDEV)
• 5-10% small-cap or small-cap-value (IUSN or ZPRV)
• 0-5% additional factor (quality, momentum)

When value doesn't make sense

• Short-term horizon (under 10 years): value droughts have lasted a full decade. You need patience.
• Concentrated value exposure (over 30% of equity): single-factor concentration creates tracking-error stress vs broad-market benchmarks you see in financial media daily.
• Belief that intangibles permanently changed the game: if you accept the structural argument that software / network-effect business models have eliminated mean reversion, holding value is irrational. This is a real intellectual position, not a strawman.
• Tax-inefficient implementations: rebalancing between value and growth in taxable accounts triggers capital gains. Use IKE / IKZE / PEA-equivalent wrappers where possible.

Worked example: 100k EUR with 10% value tilt over 20 years

Assumptions: starting balance 100,000 EUR, 20-year horizon, MSCI World 7% real annualised, MSCI World Value 8% real annualised (assuming a modest 1% premium realised over the next 20 years — far below the long-term Fama-French 4% but recognising the recent drought may not fully reverse).

Portfolio A (pure VWCE): 100,000 EUR at 7% = 386,968 EUR after 20 years

Portfolio B (90% VWCE + 10% IWFV): weighted return ≈ 7.1%, plus modest rebalancing alpha. Approximate terminal balance: 394,000-400,000 EUR.

Expected outperformance: 7,000-13,000 EUR over 20 years. Smaller than the small-cap example because the value premium assumption is more conservative.

Optimistic scenario (value premium realises at 3% historical average): around 410,000 EUR terminal. Pessimistic scenario (value continues to underperform by 2% per year): around 375,000 EUR — behind pure VWCE.

The variance is wider for value than for small-cap because of the live debate about factor decay. Decision rests on your prior about mean reversion.

Tracking your factor tilt with Freenance

Maintaining a 10-15% value tilt across multiple brokers (TR for savings plans, IBKR for lump sums, BOSSA for IKE) makes it easy to drift away from target. Freenance aggregates positions across all major EU brokers, surfaces your actual value exposure, and alerts you when drift exceeds 2% of target. The Financial Freedom Runway projection lets you stress-test value tilt assumptions — what happens to your retirement date if the value premium is +2%, 0%, or -2%? Compare scenarios side by side.

Polish reader angle

IWFV, XDEV, ZPRV, ZPRX, IEVL are all available via https://bossa.pl and https://www.mbank.pl, primarily on Xetra. IKE / IKZE eligibility is confirmed for the major issuers (iShares, SPDR, Xtrackers).

For Polish investors specifically, ZPRX (MSCI Europe Small Cap Value Weighted) offers an interesting combination — European small-cap value tilt with no W-8BEN complexity (IE-domiciled UCITS), no US tax leakage, and natural EUR exposure that partially hedges PLN/EUR risk for euro-area asset allocation.

W-8BEN is not relevant for IE-domiciled UCITS. Polish brokers do not provide access to US-domiciled value funds (VOOV, AVUV, DFA) under PRIIPs / KID rules, so the question does not arise in practice.

Belka tax of 19% applies at sale outside IKE / IKZE wrappers. Long-horizon value tilts (15-20 years) align well with IKE's tax-free withdrawal at age 60.

FAQ

Is value investing dead? The 2010-2020 drought was historically extreme but not unique — value also underperformed during the late 1990s. Subsequent recovery in early 2000s was strong. Current valuation spread (value vs growth) is at multi-decade extremes, suggesting mean reversion is plausible but not guaranteed. Factor researchers (Fama, French, AQR, Asness) maintain the factor exists, partly because the underlying mechanism (behavioural over-extrapolation, risk premium for distressed firms) hasn't disappeared.

How much value tilt is too much? Most practitioner allocations stay between 5% and 20% of equity. Above 30% you become an active value manager exposed to extended underperformance vs cap-weighted peers.

Should I prefer ZPRV (small + value) or IWFV (large + value)? Small-value historically delivered the strongest premiums (Fama-French combined factor effect). But small-value also has the worst recent decade — both small and value lagged simultaneously. ZPRV has higher expected premium but higher variance. IWFV / XDEV give cleaner large-cap value exposure.

Why has Berkshire Hathaway done well if value is dead? Buffett's approach blends value with quality (high ROE, durable franchises) rather than pure book-to-price. Quality-screened value has performed better than pure value over the last decade. This supports the value + quality combination approach.

Should I use savings plans for value ETFs? Yes, for the same reason as small-cap — dollar-cost averaging smooths the higher volatility and removes timing pressure. Trade Republic and Scalable both offer zero-cost savings plans on the major value UCITS.

What about active value funds (DFA, Avantis equivalents)? DFA and Avantis are US-domiciled and not available to EU retail investors under PRIIPs / KID. UCITS alternatives use factor-index methodologies rather than active stock picking. JPMorgan and Robeco offer some semi-active UCITS value funds, but pure factor UCITS dominate in retail flows.

Sources

• Fama and French — "Common Risk Factors in the Returns on Stocks and Bonds" (1993)
• Kenneth French Data Library — US historical factor returns
• AQR / Asness — "The Devil in HML's Details" on value methodology
• Research Affiliates — RAFI Fundamental Index methodology
• MSCI — MSCI World Enhanced Value Index methodology and factsheet
• Issuer factsheets — iShares, SPDR, Xtrackers (KIID / KID documents)

Factor investing requires long holding periods and tolerance for relative underperformance. Educational content, not advice.